pembrolizumab
merck
['tnbc', 'pembro']
#asco22 #mlmasco - keynote-522: bcr-3 after neoadjuvant pembro-chemo in stage ii/iii tnbc implies a dismal prognosis, and should probably not continue with adjuvant pembro - 
"What we cannot speak about we must pass over in silence" (L. Wittgenstein)